Medical University Of Vienna — Sponsor Intelligence | 83 EU Trials

Filter these 83 trials by condition, phase, country and more.

Open in Search →

83 Registered trials

57 Recruiting

12 Completed trials

12 Countries active

119 Unique IMPs

100% Results reported

Phase II

Phase IV

Phase I (Other)

Phase III: 4 Phase II: 29 Phase I/II: 2 Phase III/IV: 3 Phase IV: 22 Phase I: 4 Phase I (Other): 19

100%

12 of 12 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Antidepressant therapy 2 Anhedonia 2 Ejection fraction normal 1 Polymyalgia rheumatica 1 Sinus rhythm 1 Acute graft versus host disease in skin 1 Aortic disorder 1 Dermatomyositis 1 Negative symptoms in schizophrenia 1 Schizoaffective disorder depressive type 1 Antisynthetase syndrome 1 Immune-mediated myositis 1

Top IMPs

DUPILUMAB 4 CEFAZOLIN 3 ESKETAMINE HYDROCHLORIDE 3 LANDIOLOL HYDROCHLORIDE 3 PROPOFOL 3 SODIUM CHLORIDE 3 AMPICILLIN SODIUM 2 BEVACIZUMAB 2 CEFUROXIME SODIUM 2 GENTAMICIN 2 GOZETOTIDE 2 HEPARIN SODIUM 2

All trials — page 2

83 total

TECA study Recruiting

2024-513351-33-00 Phase II 1 country TELMISARTAN
Evaluation of the Eleveld Pharmacokinetic Model for Propofol and Remifentanil in Cardiac Anesthesia with Cardiopulmonary Bypass Recruiting

2023-507808-31-00 Phase IV 1 country PROPOFOL; REMIFENTANIL
NOPE Study Recruiting

2024-513352-15-00 Phase II 1 country NORFLOXACIN
IVIG-Spare Trial Recruiting

2024-513681-19-00 Phase II 1 country UPADACITINIB
Neoadjuvant [177Lu]Lu-PSMAI&T radioligand therapy (PSMA-RLT) for patients with oligometastatic prostate cancer diagnosed using [68Ga]Ga-PSMA… Recruiting

2024-519377-18-00 Phase II 1 country GOZETOTIDE; LUTETIUM (177LU) ZADAVOTIDE GURAXETAN; STANNOUS OXIDE, 3,3-DIPHOSPHO…
Intracochlear Triamcinolone acetonide in sudden sensorineural hearing loss patients - a prospective observer blinded randomized study Recruiting

2024-513145-36-00 Phase II 1 country TRIAMCINOLONE ACETONIDE
Pulmonary pharmacokinetics of piperacillin/tazobactam and levofloxacin in patients with chronic obstructive pulmonary disease or cystic fibr… Recruiting

2024-518337-29-00 Phase IV 1 country LEVOFLOXACIN HEMIHYDRATE; PIPERACILLIN SODIUM, TAZOBACTAM SODIUM, PIPERACILLIN, …
The relationship of cholesterol-lowering drugs with steroid HORMONEs, bile acids, muscle morphology, vitamin D, the immune system and relate… Recruiting

2024-516967-10-00 Phase IV 1 country ALIROCUMAB; ATORVASTATIN; EVOLOCUMAB; INCLISIRAN; ROSUVASTATIN
The Effect of Albumin Levels on Pharmacokinetics of Cefazolin in Adult Cardiac Surgery: A Prospective, Randomized, Open-label, Parallel-grou… Recruiting

2024-518338-10-00 Phase IV 1 country CEFAZOLIN; HUMAN PLASMA PROTEINS WITH NOT LESS THAN 96% ALBUMIN
[177Lu]Lu-PSMAI&T radioligand therapy (PSMA-RLT) for patients with prostate cancer and biochemical but not radio-morphological local recurre… Recruiting

2024-519348-34-00 Phase II 1 country GOZETOTIDE; LUTETIUM (177LU) ZADAVOTIDE GURAXETAN; STANNOUS OXIDE, 3,3-DIPHOSPHO…
A phase-2b controlled study to evaluate the humoral and cellular immune response and safety following one and two doses of an adjuvanted RSV… Recruiting

2024-513187-25-00 Phase II 1 country RESPIRATORY SYNCYTIAL VIRUS, GLYCOPROTEIN F, RECOMBINANT, STABILISED IN THE PRE-…
Effect of proactive therapeutic drug monitoring on maintenance of sustained disease control in adults with rheumatoid arthritis on a subcuta… Recruiting

2023-510184-35-00 Phase IV 5 countries ADALIMUMAB
Effects of Levosimendan in patients being weaned from venoarterial extracorporal membrane oxygenation. A randomized controlled investigator … Recruiting

2023-508024-36-00 Phase II 1 country LEVOSIMENDAN; RETINOL PALMITATE, ASCORBIC ACID, COLECALCIFEROL, CYANOCOBALAMIN, …
MethMax trial Recruiting

2023-507714-27-00 Phase IV 6 countries METHOTREXATE
Comparing Anticoagulation Strategies using Unfractionated heparin, Argatroban and Low-molecular-weight heparin for Extracorporeal Membrane (… Recruiting

2024-518702-40-00 Phase IV 1 country ARGATROBAN MONOHYDRATE; ENOXAPARIN SODIUM; HEPARIN SODIUM
COBRA - Chemoablation for Low Grade Bladder Cancer: A single arm, prospective, open-label, investigator-initiated Phase 2 study Recruiting

2024-517106-28-00 Phase II 1 country GEMCITABINE HYDROCHLORIDE
Clofarabine Therapy in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: a Phase 1/2 Dose-Escalation Study Recruiting

2024-516586-37-00 Phase I/II 1 country CLOFARABINE
Pharmacokinetics and penetrability of clindamycin and cefalexin into bone tissue Recruiting

2024-517873-25-00 Phase I (Other) 1 country
Efficacy and Safety of BT200 (rondaptivon pegol) in Patients with Type 2B von Willebrand disease Recruiting

2024-518294-34-01 Phase II 1 country RONDAPTIVON PEGOL
Desflurane versus Sevoflurane versus Propofol on postoperative delirium in elderly patients Recruiting

2023-503717-30-00 Phase III/IV 1 country DESFLURANE; PROPOFOL; SEVOFLURANE
A model of a sterile, self-limiting, acute inflammatory response in healthy volunteers using lipopolysaccharides – a platform trial Recruiting

2024-518768-11-02 Phase I (Other) 1 country
Single dose pharmacokinetics of selected antibiotics in plasma and soft tissues of healthy volunteers. Recruiting

2024-518260-13-00 Phase I (Other) 1 country
EPI/HIS-trial Recruiting

2024-517017-33-00 Phase I (Other) 1 country
Effect of Dupilumab an mucus plugs and inflammatory patterns in sEvere asThmAtiC paTients — a Pilot Study (DETACT) Recruiting

2024-517567-23-00 Phase III/IV 1 country DUPILUMAB

Showing 25–48 of 83 trials

← All sponsors A–Z